U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07845162) titled 'Serum EBI-3 Protein Levels in Behcet's Disease' on Sept. 22.
Brief Summary: This cross-sectional study aims to evaluate serum Epstein-Barr virus-induced gene 3 (EBI-3) protein levels in patients with Behcet's disease compared with healthy controls.
Study Start Date: Sept. 26
Study Type: OBSERVATIONAL
Condition:
Behcet Disease
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Assiut University
Information provided by (Responsible Party): Shrouk Samir Mohamed, Assiut University
Published by HT Digital Content Services with permission from Health Daily Digest....